Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation: Cochrane systematic review

Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation: Cochrane systematic review is a topic covered in the Cochrane Abstracts.

To view the entire topic, please sign in or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception

"Snowball fingers" - Image

Botulinum toxin for the treatment of strabismus: Cochrane systematic review

ACC/AHA: Fewer patients require prophylaxis for endocarditis

Citation

"Lamivudine or Adefovir Dipivoxil Alone or Combined With Immunoglobulin for Preventing Hepatitis B Recurrence After Liver Transplantation: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435284/all/Lamivudine_or_adefovir_dipivoxil_alone_or_combined_with_immunoglobulin_for_preventing_hepatitis_B_recurrence_after_liver_transplantation:_Cochrane_systematic_review. Accessed 23 January 2019.

Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435284/all/Lamivudine_or_adefovir_dipivoxil_alone_or_combined_with_immunoglobulin_for_preventing_hepatitis_B_recurrence_after_liver_transplantation:_Cochrane_systematic_review. Accessed January 23, 2019.

Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation: Cochrane systematic review. In Cochrane Abstracts. Available from https://evidence.unboundmedicine.com/evidence/view/Cochrane/435284/all/Lamivudine_or_adefovir_dipivoxil_alone_or_combined_with_immunoglobulin_for_preventing_hepatitis_B_recurrence_after_liver_transplantation:_Cochrane_systematic_review

Lamivudine or Adefovir Dipivoxil Alone or Combined With Immunoglobulin for Preventing Hepatitis B Recurrence After Liver Transplantation: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2019 January 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435284/all/Lamivudine_or_adefovir_dipivoxil_alone_or_combined_with_immunoglobulin_for_preventing_hepatitis_B_recurrence_after_liver_transplantation:_Cochrane_systematic_review

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case

TY - ELEC T1 - Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation: Cochrane systematic review ID - 435284 BT - Cochrane Abstracts UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435284/all/Lamivudine_or_adefovir_dipivoxil_alone_or_combined_with_immunoglobulin_for_preventing_hepatitis_B_recurrence_after_liver_transplantation:_Cochrane_systematic_review DB - Evidence Central DP - Unbound Medicine ER -